PreprintAll rights reservedbioRxiv
Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality
- 1Department of Medicine, Medical Faculty, Geneva University, Geneva, Switzerland. Division of Rheumatology . Geneva Center of Inflammation Research, University o
Related
- Cardiovascular and mortality outcomes with JAK versus TNF inhibitors in rheumatoid arthritis: a target trial emulation (CARDINAL-RA)
- Joint–brain communication in rheumatoid arthritis: glial mechanisms, pain phenotypes, and translational evidence
- Histone lactylation in fibroblast-like synoviocytes drives CXCL1-mediated immune cell recruitment in rheumatoid arthritis
- Identification of a shared PAX5-mediated B-cell regulatory axis in inflammatory bowel disease and rheumatoid arthritis
- Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls
BibTeX
@misc{chebbi2026serum,
title = {{Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality}},
author = {S. Chebbi and D. Mongin and D. S. Courvoisier and M. J. Nissen and B. Moeller and R. Micheroli and C. Gabay and N. Vuilleumier and A. Finckh and M. Jarlborg},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.30.763141},
url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763141v1},
}
RIS
TY - UNPB
TI - Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality
AU - S. Chebbi
AU - D. Mongin
AU - D. S. Courvoisier
AU - M. J. Nissen
AU - B. Moeller
AU - R. Micheroli
AU - C. Gabay
AU - N. Vuilleumier
AU - A. Finckh
AU - M. Jarlborg
PY - 2026
DA - 2026/10/30
PB - bioRxiv
DO - 10.64898/2026.10.30.763141
UR - https://www.biorxiv.org/content/10.64898/2026.10.30.763141v1
ER -